The MDS 2021 Organizing Committee and the MDS Foundation Board of Directors has decided to transform the 16th International Congress on Myelodysplastic Syndromes (MDS 2021) into a fully virtual meeting.
MDS 21 Virtual Congress: 23 – 26 September 2021
For more information, please click here.
EDT — Eastern Daylight Time
The official language of the congress is English. Simultaneous translation will not be provided.
Prescriber / Non-Prescriber
Support from pharmaceutical partners helps make this event possible. As such, it is important that we comply with the various codes and directives relating to the manufacturing, distribution, and marketing of pharmaceutical products. The European Union directive (2001/83/EC, article 86) provides guidelines relating to medicinal products for human use. Within these guidelines is the restriction that access to pharmaceutical product marketing activities must be limited to only those participants licensed/authorised to prescribe or supply medicinal products. All participants, with the exception of the exhibitors, are asked the following question during registration: Are you licensed/authorised to prescribe or supply prescription only medicines?
Within the virtual event platform healthcare professional authorised to prescribe prescription medicines will be recognized with a letter P (Prescriber) indicated after their names.
Within the virtual event platform, all exhibitors (booth admins) will be recognized with a letter E (Exhibitor) indicated after their names.
Rue François-Versonnex 7
1207 Geneva, Switzerland